Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials.

Journal article

Early Breast Cancer Trialists’ Collaborative group (EBCTCG) None., (2021), Lancet Oncol, 22, 1139 - 1150

Real-world outcomes in patients receiving neo-adjuvant chemotherapy for early-stage breast cancer

Conference paper

McDonald C. et al, (2021), CANCER RESEARCH, 81

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.

Journal article

Kos Z. et al, (2020), NPJ Breast Cancer, 6

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.

Journal article

Kos Z. et al, (2020), NPJ Breast Cancer, 6

Stage 1 Testicular Seminomas Treated with Single Cycle Carboplatin: Outcomes and Management of Relapse: A Single-Centre Experience

Conference paper

Kirk H. et al, (2018), INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 102, E153 - E153

Management and outcomes of stage 2a testicular seminoma: a single-centre experience

Conference paper

Kirk H. et al, (2018), CLINICAL ONCOLOGY, 30, E3 - E3

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials.

Journal article

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2018), Lancet Oncol, 19, 27 - 39

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.

Journal article

Pan H. et al, (2017), N Engl J Med, 377, 1836 - 1846

Load More